GPR43 (free fatty acid receptor 2) is known to regulate energy balance in the host through the gastrointestinal and adipose tissues, and is being explored as a potential therapeutic alternative for metabolic diseases [115,116]. The gene discussed is FFAR2; the disease is Other metabolic disease.